Senior Clinical Research Director (AI)

Location: Cambridge, MA, United States; hybrid

Salary: $236,250–$393,750 per year, commensurate with experience.

Company

hirify.global is an R&D-driven, AI-powered biopharmaceutical company developing medicines and vaccines for immune challenges, rare diseases, blood disorders, cancer, and neurological disorders.

What you will do

• Serve as the primary Clinical Lead for the fitusiran registrational development program and ongoing global regulatory submissions.
• Develop and implement clinical development strategies and oversee clinical development and study activities.
• Coordinate with Clinical Research Directors, Clinical Scientists, and cross-functional stakeholders to resolve clinical study issues.
• Contribute to clinical sections of submission dossiers, regulatory and safety documents, and agency meetings.
• Act as the medical reference for the team, ensuring the medical relevance of clinical data.
• Lead scientific data evaluation and dissemination while ensuring compliance with regulations, health authority guidance, and company policies.

Requirements

• Medical Doctor or equivalent with specialist training in Hematology, Internal Medicine, Pediatrics, or another relevant specialty.
• At least 8 years of experience in clinical development or a related area.
• Strong scientific and clinical background with deep knowledge of the therapeutic field and clinical study methodology.
• Understanding of pharmaceutical product development and lifecycle management.
• Excellent communication, problem-solving, decision-making, leadership, and cross-functional collaboration skills.
• Fluent English, spoken and written, required.

Nice to have

• MD/PhD degree.

Culture & Benefits

• Supportive, future-focused environment with opportunities for promotion and international career development.
• Health, wellbeing, prevention, and wellness benefits.
• At least 14 weeks of gender-neutral parental leave.
• Patient insights are incorporated early into drug development and study design.
• Access to AI, data, and digital platforms supporting drug discovery and development.